Stock Analysts’ price target changes for Tuesday, September 8th:
Airbnb (NASDAQ:ABNB) had its price target boosted by Robert W. Baird from $175.00 to $200.00. They currently have an outperform rating on the stock.
Absci (NASDAQ:ABSI) had its target price boosted by BTIG Research from $13.00 to $16.00. They currently have a buy rating on the stock.
AppLovin (NASDAQ:APP) had its target price cut by BTIG Research from $408.00 to $396.00. The firm currently has a buy rating on the stock.
Tritax Big Box REIT (LON:BBOX) had its price target cut by Berenberg Bank from GBX 196 to GBX 188. Berenberg Bank currently has a buy rating on the stock.
Climb Bio (NASDAQ:CLYM) had its target price raised by HC Wainwright from $24.00 to $30.00. HC Wainwright currently has a buy rating on the stock.
DraftKings (NASDAQ:DKNG) had its price target raised by Citizens Jmp from $36.00 to $37.00. Citizens Jmp currently has a market outperform rating on the stock.
Etsy (NYSE:ETSY) had its target price boosted by Argus from $67.00 to $89.00. Argus currently has a buy rating on the stock.
FactSet Research Systems (NYSE:FDS) had its price target raised by Barclays PLC from $216.00 to $250.00. They currently have an underweight rating on the stock.
FedEx (NYSE:FDX) had its price target cut by JPMorgan Chase & Co. from $460.00 to $400.00. They currently have an overweight rating on the stock.
James Fisher and Sons (LON:FSJ) had its price target trimmed by Berenberg Bank from GBX 850 to GBX 835. They currently have a buy rating on the stock.
Robinhood Markets (NASDAQ:HOOD) had its price target increased by Cantor Fitzgerald from $115.00 to $150.00. The firm currently has an overweight rating on the stock.
Hyperion DeFi (NASDAQ:HYPD) had its price target raised by Chardan Capital from $7.30 to $8.45. The firm currently has a buy rating on the stock.
Ionis Pharmaceuticals (NASDAQ:IONS) had its target price reduced by Canaccord Genuity Group Inc. from $95.00 to $85.00. They currently have a buy rating on the stock.
Ionis Pharmaceuticals (NASDAQ:IONS) had its target price trimmed by HC Wainwright from $115.00 to $100.00. The firm currently has a buy rating on the stock.
Mid-America Apartment Communities (NYSE:MAA) had its price target cut by Mizuho from $152.00 to $140.00. The firm currently has an outperform rating on the stock.
Merck & Co., Inc. (NYSE:MRK) had its price target boosted by Guggenheim from $146.00 to $170.00. They currently have a buy rating on the stock.
Strategy (NASDAQ:MSTR) had its price target increased by Canaccord Genuity Group Inc. from $175.00 to $179.00. They currently have a buy rating on the stock.
ServiceNow (NYSE:NOW) had its price target raised by BTIG Research from $150.00 to $170.00. They currently have a buy rating on the stock.
Progyny (NASDAQ:PGNY) had its target price raised by Citizens Jmp from $31.00 to $33.00. The firm currently has a market outperform rating on the stock.
Roivant Sciences (NASDAQ:ROIV) had its price target increased by Jefferies Financial Group Inc. from $42.00 to $52.00. They currently have a buy rating on the stock.
Royalty Pharma (NASDAQ:RPRX) had its target price boosted by TD Cowen from $65.00 to $68.00. They currently have a buy rating on the stock.
Range Resources (NYSE:RRC) had its target price increased by Barclays PLC from $40.00 to $42.00. The firm currently has an equal weight rating on the stock.
Science Applications International (NASDAQ:SAIC) had its target price raised by The Goldman Sachs Group, Inc. from $93.00 to $103.00. They currently have a sell rating on the stock.
SL Green Realty (NYSE:SLG) had its price target increased by Barclays PLC from $52.00 to $54.00. Barclays PLC currently has an equal weight rating on the stock.
SpaceX (NASDAQ:SPCX) had its price target lowered by Wells Fargo & Company from $215.00 to $212.00. The firm currently has an overweight rating on the stock.
Standard Chartered (LON:STAN) had its target price raised by JPMorgan Chase & Co. from GBX 2,330 to GBX 2,470. The firm currently has an overweight rating on the stock.
Symbotic (NASDAQ:SYM) had its price target trimmed by Barclays PLC from $44.00 to $38.00. The firm currently has an underweight rating on the stock.
Thomson Reuters (NASDAQ:TRI) had its target price trimmed by Barclays PLC from $140.00 to $130.00. They currently have an overweight rating on the stock.
Vera Therapeutics (NASDAQ:VERA) had its price target increased by JPMorgan Chase & Co. from $76.00 to $83.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Valero Energy (NYSE:VLO) had its price target increased by UBS Group AG from $355.00 to $450.00. They currently have a buy rating on the stock.
XPO (NYSE:XPO) had its target price cut by Citigroup Inc. from $221.00 to $220.00. Citigroup Inc. currently has a neutral rating on the stock.
Receive News & Ratings for Airbnb Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Airbnb Inc and related companies with MarketBeat.com's FREE daily email newsletter.
